Selective ablation of mast cells or basophils reduces peanut-induced anaphylaxis in mice - 27/09/13

Abstract |
Background |
Studies with c-kit mutant mast cell (MC)–deficient mice and antibody-mediated depletion of basophils suggest that both MCs and basophils can contribute to peanut-induced anaphylaxis (PIA). However, interpretation of data obtained by using such approaches is complicated because c-kit mutant mice have several phenotypic abnormalities in addition to MC deficiency and because basophil-depleting antibodies can also react with MCs.
Objective |
We analyzed (1) the changes in the features of PIA in mice after the selective and inducible ablation of MCs or basophils and (2) the possible importance of effector cells other than MCs and basophils in the PIA response.
Methods |
Wild-type and various mutant mice were orally sensitized with peanut extract and cholera toxin weekly for 4 weeks and challenged intraperitoneally with peanut extract 2 weeks later.
Results |
Peanut-challenged, MC-deficient KitW-sh/W-sh mice had reduced immediate hypothermia, as well as a late-phase decrease in body temperature that was abrogated by antibody-mediated depletion of neutrophils. Diphtheria toxin–mediated selective depletion of MCs or basophils in Mcpt5-Cre;iDTR and Mcpt8DTR mice, respectively, and treatment of wild-type mice with the basophil-depleting antibody Ba103 significantly reduced peanut-induced hypothermia. Non–c-kit mutant MC- and basophil-deficient Cpa3-Cre;Mcl-1fl/fl mice had reduced but still significant responses to peanut.
Conclusion |
Inducible and selective ablation of MCs or basophils in non–c-kit mutant mice can significantly reduce PIA, but partial responses to peanut can still be observed in the virtual absence of both cell types. The neutrophilia in KitW-sh/W-sh mice might influence the responses of these mice in this PIA model.
Le texte complet de cet article est disponible en PDF.Key words : Peanut, allergy, neutrophils, diphtheria toxin, KitW-sh/W-sh, mast cells, anaphylaxis, basophils, carboxypeptidase A3, mast cell protease 5
Abbreviations used : BMCMC, Cpa3, CTMC, DT, DTR, MC, Mcpt, MMC, PAF, PIA, PSA, WT
Plan
| L.L.R. is the recipient of fellowships from the French “Fondation pour la Recherche Médicale FRM” and the Stanford Pediatric Research Fund of the Lucile Packard Foundation for Children’s Health and the Stanford CTSA (National Institutes of Health grant UL1 RR025744). T.M. is supported by a fellowship from the Belgium American Educational Foundation and a Marie Curie International outgoing Fellowship for Career Development: 299954. K.H. acknowledges support from the German Research Council (DFG; CRC/SFB832, project A14). S.J.G. acknowledges support from National Institutes of Health grants AI023990, CA072074, and AI070813. |
|
| Disclosure of potential conflict of interest: L. L. Reber, T. Marichal, K. Mukai, M. Tsai, and S. J. Galli have been supported by grants from the National Institutes of Health (AI070813, AI023990, and AI072074). The rest of the authors declare that they have no relevant conflicts of interest. |
Vol 132 - N° 4
P. 881 - octobre 2013 Retour au numéroBienvenue sur EM-consulte, la référence des professionnels de santé.
L’accès au texte intégral de cet article nécessite un abonnement.
Déjà abonné à cette revue ?
